Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial.
Saved in:
| Title: | Evaluating tocilizumab in ischemic stroke: Findings from the SPAN multicenter trial. |
|---|---|
| Authors: | Chauhan A; Department of Neurology, McGovern Medical School, University of Texas HSC, Houston, TX, USA., Lee EA; Department of Neurology, McGovern Medical School, University of Texas HSC, Houston, TX, USA., Patel RB; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Kumskova M; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Leira EC; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA., Chauhan AK; Departments of Neurology, Neurosurgery, and Epidemiology, University of Iowa, Iowa City, IA, USA., Shi Y; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA., Cao S; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA., Koehler RC; Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA., Dhandapani KM; Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA., Khan MB; Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA., Kamat PK; Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA., Arbab A; Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA., Hess DC; Department of Neurosurgery, Medical College of Georgia, Augusta University, Augusta, GA, USA., Herman AL; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Boisserand L; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Sansing LH; Department of Neurology, Yale University School of Medicine, New Haven, CT, USA., Morais A; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, 02114, USA., Jin X; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, 02114, USA., Aykan S; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, 02114, USA., Imai T; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, 02114, USA., Ayata C; Department of Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, MA, 02114, USA., Nagarkatti KA; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine at USC, Los Angeles, CA, USA., Lamb J; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine at USC, Los Angeles, CA, USA., Diniz MA; Department of Population Health Science and Policy, Icahn School of Medicine, Mount Sinai, NY, NY, USA., Lyden PD; Department of Physiology and Neuroscience, Zilkha Neurogenetic Institute, Keck School of Medicine at USC, Los Angeles, CA, USA; Department of Neurology, Keck School of Medicine at USC, Los Angeles, CA, USA., McCullough LD; Department of Neurology, McGovern Medical School, University of Texas HSC, Houston, TX, USA., Aronowski J; Department of Neurology, McGovern Medical School, University of Texas HSC, Houston, TX, USA. Electronic address: J.Aronowski@uth.tmc.edu. |
| Source: | Neuropharmacology [Neuropharmacology] 2026 Mar 01; Vol. 285, pp. 110801. Date of Electronic Publication: 2025 Dec 05. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 0236217 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7064 (Electronic) Linking ISSN: 00283908 NLM ISO Abbreviation: Neuropharmacology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
